Cheryl Descipio, PhD accepts new patients on Medical News Today.
Cheryl Descipio, PhD
Be the first to review this provider!
New York, NY
Accepting new patients
Clinical Overview
Cheryl Descipio, PhD works in New York, NY as
Office Locations
-
Office462 1st Ave Rm 4W1, New York, NY 10016
Patient Experience & Satisfaction
Be the first to leave a review
How likely are you to recommend Cheryl Descipio?
Step 1 of 3
Your review of Cheryl Descipio, PhD
50 characters remaining
1000 characters remaining
Was this a Telehealth appointment?
(This will display with your review)
Your email is used to confirm your review and will NOT appear in the review.
This name will appear with your review. If left blank, we'll use "Anonymous".
RVO Health property, Medical News Today, is owned by RVO Health. Please review our terms of use for more.
Help other patients find the right care by sharing a few more details about your visit.
Last step! Confirm your email.
We've sent an email to
Once you confirm, you can close this window.
Thank you for your review!
Your review has been confirmed and will be published after verification.
Thank you for your review!
We've sent a confirmation email. Your review will appear after you confirm it.
Please allow up to 30 seconds for the email to arrive. Don't see it? Make sure to check your 'spam' and 'updates' folder. Once you've confirmed your review, you can close this window.
Medical Expertise & Background
Specialties*
Pathology Technology
- *Medical News Today does not verify qualifications for medical specialties. Please verify your provider's specialty and qualifications directly with your provider and applicable medical board.
Common Patient Questions
Cheryl Descipio's office is located at 462 1st Ave Rm 4W1 New York, NY 10016. Get a map and directions to Cheryl Descipio's office here.
Cheryl Descipio does not have any reviews yet.
Claim Your Profile
Are you Cheryl Descipio, PhD?
Know Before You Go
Preventive care: what doctors want you to know
Preventive care can help identify current or future health and medical concerns before they become major.
Featured Stories
Updated migraine guidance from the American Academy of Neurology and the American Headache Society includes both established medications and newer preventive treatments, such as therapies targeting the GCRP pathways, replacing guidelines from 2012.
A new heart health study found that people with the highest levels of the sweetener xylitol in their blood had a 57% higher risk of major adverse cardiovascular events.
Memory may start to naturally decline earlier than scientists had previously thought, according to recent findings.
